These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 25990457)
1. Regulation of AURKC expression by CpG island methylation in human cancer cells. Fujii S; Srivastava V; Hegde A; Kondo Y; Shen L; Hoshino K; Gonzalez Y; Wang J; Sasai K; Ma X; Katayama H; Estecio MR; Hamilton SR; Wistuba I; Issa JP; Sen S Tumour Biol; 2015 Sep; 36(10):8147-58. PubMed ID: 25990457 [TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
3. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation. Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911 [TBL] [Abstract][Full Text] [Related]
4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation. Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146 [TBL] [Abstract][Full Text] [Related]
6. CpG island methylation status in the EpCAM promoter region and gene expression. Yu G; Zhang X; Wang H; Rui D; Yin A; Qiu G; He Y Oncol Rep; 2008 Nov; 20(5):1061-7. PubMed ID: 18949402 [TBL] [Abstract][Full Text] [Related]
7. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347 [TBL] [Abstract][Full Text] [Related]
8. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. Tang H; Goldberg E J Androl; 2009; 30(2):157-67. PubMed ID: 18930904 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells. Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657 [TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines. Mobasheri MB; Shirkoohi R; Zendehdel K; Jahanzad I; Talebi S; Afsharpad M; Modarressi MH Tumour Biol; 2015 Sep; 36(10):8201-6. PubMed ID: 25994570 [TBL] [Abstract][Full Text] [Related]
11. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer. Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031 [TBL] [Abstract][Full Text] [Related]
12. DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers. Peng J; Chen B; Shen Z; Deng H; Liu D; Xie X; Gan X; Xu X; Huang Z; Chen J Int J Clin Exp Pathol; 2015; 8(9):11042-50. PubMed ID: 26617822 [TBL] [Abstract][Full Text] [Related]
13. Differential methylation of CpG islands within the dermo1 gene promoter in several cancer cell lines. Mao Y; Toh HB; Ding Z; Sun L; Hong L; Chen CS; Wu X Oncol Rep; 2011 Jan; 25(1):107-11. PubMed ID: 21109964 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic control of group V phospholipase A2 expression in human malignant cells. Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Mareninova OA; Asatryan L; Siegert G Tumour Biol; 2016 Jun; 37(6):8097-105. PubMed ID: 26715269 [TBL] [Abstract][Full Text] [Related]
15. Frequent inactivation of hSRBC in ovarian cancers by promoter CpG island hypermethylation. Tong SY; Ki KD; Lee JM; Kang MJ; Ha TK; Chung SI; Chi SG; Lee SK Acta Obstet Gynecol Scand; 2010 May; 89(5):629-35. PubMed ID: 20423276 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis. Shin SH; Park SY; Kang GH Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999 [TBL] [Abstract][Full Text] [Related]
17. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene. Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589 [TBL] [Abstract][Full Text] [Related]
18. Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells. Hisano M; Ohta H; Nishimune Y; Nozaki M Nucleic Acids Res; 2003 Aug; 31(16):4797-804. PubMed ID: 12907721 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832 [TBL] [Abstract][Full Text] [Related]
20. DNA methylation of a non-CpG island promoter represses NQO1 expression in rat arsenic-transformed lung epithelial cells. Huang N; Pei X; Lin W; Chiu JF; Tao T; Li G Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):733-739. PubMed ID: 29889218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]